Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  1,177 results for ""Angiotensin II Type 1 Receptor Blockers""

Your Filters

Publisher : elsevier
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Reduction of Aversive Learning Rates in Pavlovian Conditioning by Angiotensin II Antagonist Losartan: A Randomized Controlled Trial.

  • Authors : Zika O; Max Planck Institute for Human Development, Berlin, Germany.; Appel J

Subjects: Losartan*/Losartan*/Losartan*/pharmacology ; Losartan*/Losartan*/Losartan*/administration & dosage ; Conditioning, Classical*/Conditioning, Classical*/Conditioning, Classical*/drug effects

  • Source: Biological psychiatry [Biol Psychiatry] 2024 Aug 15; Vol. 96 (4), pp. 247-255. Date of Electronic Publication: 2024 Feb 02.Publisher: Elsevier Country of Publication: United States NLM ID: 0213264 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Valsartan as a prophylactic treatment against breast cancer development and niche activation: What molecular sequels follow chronic AT-1R blockade?

  • Authors : Mansour AMA; Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Pharos University in Alexandria, Alexandria, Egypt.; Khattab MM

Subjects: Valsartan*/Valsartan*/Valsartan*/pharmacology ; Receptor, Angiotensin, Type 1*/Receptor, Angiotensin, Type 1*/Receptor, Angiotensin, Type 1*/metabolism ; Receptor, IGF Type 1*/Receptor, IGF Type 1*/Receptor, IGF Type 1*/metabolism

  • Source: Life sciences [Life Sci] 2024 Sep 15; Vol. 353, pp. 122939. Date of Electronic Publication: 2024 Jul 31.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0375521 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Report

Collagenous Sprue and Olmesartan: another pathological condition related to this drug.

  • Authors : Del Sordo R; Department of Medicine and Surgery, Section of Anatomic Pathology and Histology, Medical School, University of Perugia, P.za, Lucio Severi 1, Perugia 06132, Italy. Electronic address: .; Villanacci V

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*adverse effects ; Collagenous Sprue/Collagenous Sprue/Collagenous Sprue/*chemically induced ; Olmesartan Medoxomil/Olmesartan Medoxomil/Olmesartan Medoxomil/*adverse effects

  • Source: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2021 Nov; Vol. 53 (11), Publisher: Elsevier Country of Publication: Netherlands NLM ID: 100958385 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Olmesartan associated enteropathy. A multiface clinical and histological entity.

  • Authors : Del Sordo R; Department of Medicine and Surgery, Section of Anatomic Pathology and Histology, Medical School, University of Perugia, Ospedale Santa Maria della Misericordia, P.za, Lucio Severi 1, Perugia 06132, Italy. Electronic address: .; Riccardi L

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*adverse effects ; Colonic Diseases/Colonic Diseases/Colonic Diseases/*chemically induced ; Imidazoles/Imidazoles/Imidazoles/*adverse effects

  • Source: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2021 May; Vol. 53 (5), pp.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 100958385 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Targeting the renin angiotensin system for the treatment of anxiety and depression.

  • Authors : Chrissobolis S; Department of Pharmaceutical and Biomedical Sciences, The Raabe College of Pharmacy, Ohio Northern University, 525 S Main Street, Ada, OH 45810, United States of America.; Luu AN

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*pharmacology ; Antidepressive Agents/Antidepressive Agents/Antidepressive Agents/*pharmacology ; Antidepressive Agents/Antidepressive Agents/Antidepressive Agents/*therapeutic use

  • Source: Pharmacology, biochemistry, and behavior [Pharmacol Biochem Behav] 2020 Dec; Vol. 199, pp. 173063. Date of Electronic Publication: 2020 Oct 26.Publisher: Elsevier Country of Publication: United States NLM ID: 0367050 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Can a Combination of AT1R Antagonist and Vitamin D Treat the Lung Complication of COVID-19?

  • Authors : Rafiullah M; Strategic Center for Diabetes Research, College of Medicine, King Saud University, Riyadh, Saudi Arabia. Electronic address: .

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Coronavirus Infections/Coronavirus Infections/Coronavirus Infections/*drug therapy ; Pneumonia, Viral/Pneumonia, Viral/Pneumonia, Viral/*drug therapy

  • Source: The American journal of the medical sciences [Am J Med Sci] 2020 Oct; Vol. 360 (4), pp. 338-341. Date of Electronic Publication: 2020 Jul 15.Publisher: Elsevier Country of Publication: United States NLM ID: 0370506 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Trends in ACEi and ARB expenditure: Compelling case for competition in generic drug markets.

  • Authors : Batty JA; Clinical and Population Sciences Department, Leeds Institute of Cardiovascular and Metabolic Medicine, Worsley Building, Clarendon Way, University of Leeds, LS2 9NL, UK; Leeds Institute for Data Analytics, Worsley Building, Clarendon Way, University of Leeds, LS2 9NL, UK. Electronic address: .

Subjects: Angiotensin Receptor Antagonists* ; Angiotensin-Converting Enzyme Inhibitors*/Angiotensin-Converting Enzyme Inhibitors*/Angiotensin-Converting Enzyme Inhibitors*/therapeutic use; Humans

  • Source: International journal of cardiology [Int J Cardiol] 2023 Jan 01; Vol. 370, pp. 419-420. Date of Electronic Publication: 2022 Nov 19.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8200291 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Telmisartan attenuates obesity-induced insulin resistance via suppression of AMPK mediated ER stress.

  • Authors : Huang Y; Department of Pharmacy and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, China; Laboratory of Clinical Pharmacy and Adverse Drug Reaction, West China Hospital, Sichuan University, China.

Subjects: Insulin Resistance*; AMP-Activated Protein Kinases/AMP-Activated Protein Kinases/AMP-Activated Protein Kinases/*metabolism ; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use

  • Source: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2020 Mar 12; Vol. 523 (3), pp. 787-794. Date of Electronic Publication: 2020 Jan 14.Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Systematic characterization of AT1 receptor antagonists with label-free dynamic mass redistribution assays.

  • Authors : Qu L; Key Lab of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China; University of Chinese Academy of Sciences, Beijing 100049, China.

Subjects: Angiotensin II/Angiotensin II/Angiotensin II/*metabolism ; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*pharmacology ; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*pharmacology

  • Source: Journal of pharmacological and toxicological methods [J Pharmacol Toxicol Methods] 2020 Mar - Apr; Vol. 102, pp. 106682. Date of Electronic Publication: 2020 Feb 20.Publisher: Elsevier Country of Publication: United States NLM ID: 9206091 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial.

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*administration & dosage ; Aorta/Aorta/Aorta/*diagnostic imaging ; Irbesartan/Irbesartan/Irbesartan/*administration & dosage

  • Source: Lancet (London, England) [Lancet] 2019 Dec 21; Vol. 394 (10216), pp. 2263-2270. Date of Electronic Publication: 2019 Dec 10.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  1,177 results for ""Angiotensin II Type 1 Receptor Blockers""